Pennsylvania Department of Health
KADIMA REHABILITATION & NURSING AT NEW WILMINGTON
Patient Care Inspection Results

Note: If you need to change the font size, click the "View" menu at the top of the page, place the mouse over the "Text Size" menu item, and select the desired font size.

Severity Designations

Click here for definitions Click here for definitions Click here for definitions Click here for definitions
Minimal Citation - No Harm Minimal Harm Actual Harm Serious Harm
KADIMA REHABILITATION & NURSING AT NEW WILMINGTON
Inspection Results For:

There are  148 surveys for this facility. Please select a date to view the survey results.

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
KADIMA REHABILITATION & NURSING AT NEW WILMINGTON - Inspection Results Scope of Citation
Number of Residents Affected
By Deficient Practice
Initial comments:

Based on a Medicare/Medicaid Recertification, State Licensure, and Civil Rights Compliance Survey and an Abbreviated Complaint Survey completed on March 6, 2026, it was determined that Kadima Rehabilitation and Nursing at New Wilmington was not in compliance with the following requirements of 42 CFR Part 483, Subpart B, Requirements for Long Term Care Facilities and the 28 PA Code, Commonwealth of Pennsylvania Long Term Care Licensure Regulations.




 Plan of Correction:


483.45(g)(h)(1)(2) REQUIREMENT Label/Store Drugs and Biologicals:This is a less serious (but not lowest level) deficiency and affects more than a limited number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status. This deficiency was not found to be throughout this facility.
§483.45(g) Labeling of Drugs and Biologicals
Drugs and biologicals used in the facility must be labeled in accordance with currently accepted professional principles, and include the appropriate accessory and cautionary instructions, and the expiration date when applicable.

§483.45(h) Storage of Drugs and Biologicals

§483.45(h)(1) In accordance with State and Federal laws, the facility must store all drugs and biologicals in locked compartments under proper temperature controls, and permit only authorized personnel to have access to the keys.

§483.45(h)(2) The facility must provide separately locked, permanently affixed compartments for storage of controlled drugs listed in Schedule II of the Comprehensive Drug Abuse Prevention and Control Act of 1976 and other drugs subject to abuse, except when the facility uses single unit package drug distribution systems in which the quantity stored is minimal and a missing dose can be readily detected.
Observations:

Based on review of facility policies, observations, and staff interviews, it was determined that the facility failed to appropriately discard outdated medications for three of four medication carts reviewed (North two, South, and West medication carts).

Findings include:

Review of facility policy entitled "Vials and Ampules of Injectable Medications" dated 2/24/26, indicated "The beyond use date ... are recorded on the multidose vials. And "Medications in multidose vials may be used for twenty-eight days ..."

Review of facility policy entitled "Storage of Medications" dated 2/24/26, indicated "medications and biologicals are stored ... following manufacturer's recommendations or those of the supplier." And "Outdated, contaminated, or deteriorated medications ... are immediately removed from stock, disposed of ..."

Review of manufacturer's guidelines revealed that an open pen of Humalog Insulin must be used within 28 days after opening or be discarded.

Manufacturer's guidelines for Trelegy Ellipta (medication used to treat Chronic Obstructive Pulmonary Disease [COPD a condition that prevents airflow to the lungs resulting in difficulty breathing] and Asthma [a long-term inflammatory disease of the airways that cause the airways to narrow and swell causing symptoms such as wheezing, coughing, chest tightness, and shortness of breath], indicated that Trelegy should be discarded six weeks after opening the foil tray or when the counter read "0," whichever comes first.

Manufacturer's guidelines for Serevent Diskus (a medication used to treat asthma and COPD), indicated that Serevent should be discarded six weeks after opening the foil tray or when the counter read "0," whichever comes first.

Manufacturer's guidelines for Fluticasone Propionate/Furoate Diskus (medication used to treat asthma), indicated that Serevent should be discarded six weeks or two months after opening the foil pouch or when the counter read "0," whichever comes first.

Observation of drug storage on 3/3/26, at 1:27 p.m. of the North two medication cart revealed a Serevent Diskus out of the foil package and lacking an open date.

During an interview on 3/3/26, at the time of observation Licensed Practical Nurse (LPN) Employee E1 confirmed that the Serevent lacked an open date, and staff were unable to determine the discard date. He/she also confirmed that the Serevent should have been discarded.

Observation of drug storage on 3/3/26, at 1:35 p.m. of the South medication cart revealed three Trelegy Ellipta Diskus out of the foil packages, and lacking open dates.

During an interview of 3/3/26, at the time of observation LPN Employee E2, confirmed that the three Trelegy Ellipta Diskus lacked open dates, and staff were unable to determine the discarded dates. He/she also confirmed that the three Trelegy Ellipta Diskus should have been discarded.

Observation of drug storage on 3/3/36, at 3:05 p.m. of the West medication cart revealed two Trelegy Ellipta Diskus out of the foil package and in use, one with an open date of 12/1/25, and the other one lacking an open date; two Fluticasone Propionate Diskus out of the foil packages and in use with open dates of 12/12/25; a Fluticasone Furoate Diskus out of the foil package, in use and lacking an open date; and an open, in use insulin pen of Humalog with an expiration date of 2/26/26.

During an interview on 3/3/26, at the time of observations LPN Employee E3 confirmed that one of the Trelegy Ellipta Diskus was beyond its use by date and the other one lacked an open date and staff were unable to determine the discarded date; the two Fluticasone Propionate Diskus were beyond their use by dates; and the Fluticasone Furoate Diskus lacked an open date and staff were unable to determine the discarded date and that the Humalog insulin pen had an expiration date of 2/26/26. He/she also confirmed that the Trelegy Ellipta Diskus, Fluticasone Propionate/Furoate Diskus, and the Humalog insulin pen should have all been discarded.


28 Pa. Code 201.18(b)(1) Management

28 Pa. Code 211.9(a)(1) Pharmacy services

28 Pa. Code 211.12(d)(1) Nursing services



 Plan of Correction - To be completed: 04/30/2026

1. All medications found out of the original packaging, expired or missing an open date were immediately removed from use and discarded per facility protocol. Replacement medications were obtained from the pharmacy.

2. The director of nursing/designee will re-educate all licensed nurses on proper medication storage, including maintaining medications in original packaging and dating all medications upon opening

3. The director of nursing/designee will audit the medication carts weekly for one month and monthly for three months to ensure proper packaging and presence of open dates on medications.

4. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.10(e)(1), 483.12(a)(2), 483.45(c)(3)(d)(e) REQUIREMENT Right to be Free from Chemical Restraints:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.10(e) Respect and Dignity.
The resident has a right to be treated with respect and dignity, including:

§483.10(e)(1) The right to be free from any . . . chemical restraints
imposed for purposes of discipline or convenience, and not required to treat the
resident's medical symptoms, consistent with §483.12(a)(2).

§483.12
The resident has the right to be free from abuse, neglect, misappropriation of
resident property, and exploitation as defined in this subpart. This includes but is
not limited to freedom from corporal punishment, involuntary seclusion and any
physical or chemical restraint not required to treat the resident's medical
symptoms.
§483.12(a) The facility must-. . .
§483.12(a)(2) Ensure that the resident is free from . . . chemical restraints
imposed for purposes of discipline or convenience and that are not required to treat the resident's medical symptoms.
. . . .
§483.45(c)(3) A psychotropic drug is any drug that affects brain activities associated with mental processes and behavior. These drugs include, but are not limited to, drugs in the following categories:
(i) Anti-psychotic;
(ii) Anti-depressant;
(iii) Anti-anxiety; and
(iv) Hypnotic.

§483.45(d) Unnecessary drugs-General. Each resident's drug regimen must be free from unnecessary drugs. An unnecessary drug is any drug when used-
(1) In excessive dose (including duplicate drug therapy); or
(2) For excessive duration; or
(3) Without adequate monitoring; or
(4) Without adequate indications for its use; or
(5) In the presence of adverse consequences which indicate the dose should be reduced or discontinued; or
(6) Any combinations of the reasons stated in paragraphs (d)(1) through (5) of this section.

§483.45(e) Psychotropic Drugs. Based on a comprehensive assessment of a resident, the facility must ensure that--

§483.45(e)(1) Residents who have not used psychotropic drugs are not given these drugs unless the medication is necessary to treat a specific condition as diagnosed and documented in the clinical record;

§483.45(e)(2) Residents who use psychotropic drugs receive gradual dose reductions, and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs;

§483.45(e)(3) Residents do not receive psychotropic drugs pursuant to a PRN order unless that medication is necessary to treat a diagnosed specific condition that is documented in the clinical record; and

§483.45(e)(4) PRN orders for psychotropic drugs are limited to 14 days. Except as provided in §483.45(e)(5), if the attending physician or prescribing practitioner believes that it is appropriate for the PRN order to be extended beyond 14 days, he or she should document their rationale in the resident's medical record and indicate the duration for the PRN order.

§483.45(e)(5) PRN orders for anti-psychotic drugs are limited to 14 days and cannot be renewed unless the attending physician or prescribing practitioner evaluates the resident for the appropriateness of that medication.
Observations:

Based on review of facility policy and clinical records, and staff interview, it was determined that the facility failed to provide evidence that non-pharmacological interventions (interventions attempted to calm a resident other than medication) were attempted prior to the administration of an as needed (PRN) psychotropic (mind altering) medication for two of six residents reviewed (Residents R23 and R51).

Findings include:

A facility policy entitled "Use of Psychotropic Medication" dated 2/24/26, indicated that "Non-pharmacological approaches must be attempted unless clinically contraindicated, to minimize the need for psychotropic medications ..."

Review of Resident R23's clinical record revealed an admission date of 10/25/24, with diagnoses that included anxiety (a condition that causes a person to be nervous, uneasy, or worried about something or someone), chronic obstructive pulmonary disease (when your lungs do not have adequate air flow), and diabetes (a health condition that is caused by the body's inability to produce enough insulin).

Review of Resident R23's physician's orders revealed an order dated 9/26/25, to administer Lorazepam (anti-anxiety) 0.5 milliliter (ml) by mouth every four hours PRN for anxiety.

Review of Resident R23's January 2026, February 2026, and March 2026 Medication Administration Records (MARs) revealed that the PRN Ativan was used on 1/2/26, 1/3/26, 1/6/26, 1/7/26, 1/9/26, 1/10/26, 1/13/26, 1/14/26, 1/15/26, 1/16/26, 1/20/26, 1/24/26, 2/3/26, 2/6/26, 2/7/26, 2/8/26, 2/10/26, 2/11/26, 2/16/26, 2/17/26, 2/19/26, and 3/4/26. The clinical record lacked evidence of non-pharmacological interventions being attempted prior to the administration of the PRN Lorazepam for the administrations listed above in January 2026, February 2026, and March 2026.

Review of Resident R51's clinical record revealed an admission date of 4/4/25, with diagnoses that included dysphagia (difficulty swallowing), hypertension (high blood pressure), and anxiety.

Review of Resident R51's physician's orders revealed an order dated 1/22/26, to administer Vistaril (anti-anxiety) 50 milligrams (mg) by mouth every eight hours PRN for anxiety.

Review of Resident R51's January 2026, February 2026, and March 2026 MARs revealed that the PRN Vistaril was used on 1/27/26, 2/1/26, 2/9/26, 2/18/26, 2/23/26, 2/2526, and 3/5/26. The clinical record lacked evidence of non-pharmacological interventions being attempted prior to the administration of the PRN Vistaril for the administrations listed above in January 2026, February 2026, and March 2026.

During an interview on 3/5/26, at 3:37 p.m. the Director of Nursing confirmed that Resident R23 and Resident R51's clinical records lacked evidence that non-pharmacological interventions were attempted prior to the administration of a PRN psychotropic medication for the dates listed above and that non-pharmacological interventions should be attempted and documented in the clinical record.

28 Pa. Code 211.12(d)(1)(3)(5) Nursing services



 Plan of Correction - To be completed: 04/30/2026

"The Facility submits this Plan of Correction under procedures established by the Department of Health in order to comply with the Department's directive to change conditions which the Department alleges is deficient under State and/or Federal Long Term Care Regulations. This Plan of Correction should not be construed as either a waiver of the facility's right to appeal or challenge the accuracy or severity of the alleged deficiencies or an admission of past or ongoing violation of State or Federal regulatory requirements."

1. The facility can't correct the past medication administration without evidence of non-pharmacological interventions being attempted for residents R23 and R51.

2. All residents receiving psychotropic medications will be reviewed to ensure non-pharmacological interventions are attempted prior to medication administration.

3. The Director of Nursing/designee will re-educate all licensed nurses on non-pharmacological approaches to attempt prior to utilizing psychotropic medications.

4. The director of nursing/designee will audit residents on psychotropic medications have documented non-pharmacological interventions attempted prior to a psychotropic medication being administered. The audit will be completed on five residents per week for one month and then monthly for three months.

5. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.80(a)(1)(2)(4)(e)(f) REQUIREMENT Infection Prevention & Control:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.80 Infection Control
The facility must establish and maintain an infection prevention and control program designed to provide a safe, sanitary and comfortable environment and to help prevent the development and transmission of communicable diseases and infections.

§483.80(a) Infection prevention and control program.
The facility must establish an infection prevention and control program (IPCP) that must include, at a minimum, the following elements:

§483.80(a)(1) A system for preventing, identifying, reporting, investigating, and controlling infections and communicable diseases for all residents, staff, volunteers, visitors, and other individuals providing services under a contractual arrangement based upon the facility assessment conducted according to §483.71 and following accepted national standards;

§483.80(a)(2) Written standards, policies, and procedures for the program, which must include, but are not limited to:
(i) A system of surveillance designed to identify possible communicable diseases or
infections before they can spread to other persons in the facility;
(ii) When and to whom possible incidents of communicable disease or infections should be reported;
(iii) Standard and transmission-based precautions to be followed to prevent spread of infections;
(iv)When and how isolation should be used for a resident; including but not limited to:
(A) The type and duration of the isolation, depending upon the infectious agent or organism involved, and
(B) A requirement that the isolation should be the least restrictive possible for the resident under the circumstances.
(v) The circumstances under which the facility must prohibit employees with a communicable disease or infected skin lesions from direct contact with residents or their food, if direct contact will transmit the disease; and
(vi)The hand hygiene procedures to be followed by staff involved in direct resident contact.

§483.80(a)(4) A system for recording incidents identified under the facility's IPCP and the corrective actions taken by the facility.

§483.80(e) Linens.
Personnel must handle, store, process, and transport linens so as to prevent the spread of infection.

§483.80(f) Annual review.
The facility will conduct an annual review of its IPCP and update their program, as necessary.
Observations:

Based on review of facility policy, observations, and staff interviews, it was determined that the facility failed to prevent the potential for cross-contamination (transfer of germs from one location to another) during medication administration (West Wing medication cart) and failed to prevent cross-contamination for one resident (Resident R122) receiving nebulizer treatments ( a treatment that delivers medication directly to the lungs to treat respiratory conditions).

Findings include:

Review of facility policy entitled "Medication Administration" dated 2/24/26, revealed that "If breaking tablets ... hands are washed with soap and water or alcohol gel prior to handling tablets ..."

Review of facility policy entitled "Nebulizer Equipment Management" dated 2/24/26, revealed "The facility will ensure that nebulizer used for medication administration is maintained ... with infection control standards to prevent cross-contamination ..." and "Nebulizer ... mouthpiece must be replaced at least once every seven days (weekly). Equipment must also be replaced immediately if: It becomes visibly soiled or contaminated ..."

Observations during medication administration on 3/4/26, at 8:00 a.m. revealed Licensed Practical Nurse (LPN) Employee E3 preparing medications from the West Wing medication cart. LPN Employee E3 touched a pill from a bottle without sanitizing/washing his/her hands or applying gloves. He/she then proceeded to place the pill into the medication cup with other pills. Further observations revealed that LPN Employee E3 dropped pills onto the floor and then proceeded to pick the pills up and placed them into the medication cup.

During an interview on 3/4/26, at the time of observations LPN Employee E3 confirmed that he/she did not sanitize/wash his/her hands or apply gloves before touching a pill and he/she picked pills up off the floor and placed them in the medication cup. LPN Employee E3 also confirmed that he/she should not touch medications without sanitizing/washing his/her hands or applying gloves or place medications off the floor into the medication cup.

Review of Resident R122's clinical record revealed an admission date of 2/26/26, with diagnoses that included coronary artery bypass graft (an open-heart surgery that creates a new path for blood flow), diabetes (a health condition that is caused by the body's inability to produce enough insulin), and hypertension (high blood pressure).

Review of Resident R122's physician's orders revealed an order Ipratropium Albuterol (a liquid medication) solution 3 mg per ml every four hours.

Observations on 3/3/26, at 11:00 a.m. and again at 1:03 p.m. revealed a nebulizer machine (a medical device that turns liquid medication into a fine mist) sitting on the bedside stand next to Resident R122's bed with a hand held mouth piece (a device that is connected to a nebulizer machine allowing a person to inhale medication directly into their lungs) lying on the floor and lacking a date.

During an interview on 3/3/36 at 1:20 p.m. the Director of Nursing (DON) confirmed that the mouthpiece was lying on the floor and lacked a date. The DON also confirmed that the mouthpiece should not be on the floor and that it should have a date indicating when it was placed.


28 Pa. Code 211.10(c) Resident care policies

28 Pa. Code 211.12(d)(1)(5) Nursing services





 Plan of Correction - To be completed: 04/30/2026

1. The identified concerns related to medication administration and nebulizer equipment were immediately corrected. The employee involved came to the Director of nursing and reported the concerns with her medication pass. The employee was immediately re-educated on proper infection control practices, including hand hygiene, dating and proper storage of nebulizer equipment

2. The director of nursing/designee will re-educate all licensed nurses on infection control practices during medication administration including hand hygiene and proper storage of nebulizer equipment including dating the tubing.

3. The director of nursing/designee will audit medication administration weekly for one month and them monthly for three months to ensure nurses are compliant with infection control practices including hand hygiene and proper handling of medications if dropped on the floor. It will also include proper labeling and storage of nebulizer equipment. The audits will be completed on different shifts and weekends.

4. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.15(c)(2)(iii)(3)-(6)(8)(d)(1)(2); 483.21(c)(2)(i)-(iii) REQUIREMENT Discharge Process:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.15(c)(2) Documentation.
When the facility transfers or discharges a resident under any of the circumstances specified in paragraphs (c)(1)(i)(A) through (F) of this section, the facility must ensure that the transfer or discharge is documented in the resident's medical record and appropriate information is communicated to the receiving health care institution or provider.
(iii) Information provided to the receiving provider must include a minimum of the following:
(A) Contact information of the practitioner responsible for the care of the resident.
(B) Resident representative information including contact information
(C) Advance Directive information
(D) All special instructions or precautions for ongoing care, as appropriate.
(E) Comprehensive care plan goals;
(F) All other necessary information, including a copy of the resident's discharge summary, consistent with §483.21(c)(2) as applicable, and any other documentation, as applicable, to ensure a safe and effective transition of care.

§483.15(c)(3) Notice before transfer.
Before a facility transfers or discharges a resident, the facility must-
(i) Notify the resident and the resident's representative(s) of the transfer or discharge and the reasons for the move in writing and in a language and manner they understand. The facility must send a copy of the notice to a representative of the Office of the State Long-Term Care Ombudsman.
(ii) Record the reasons for the transfer or discharge in the resident's medical record in accordance with paragraph (c)(2) of this section; and
(iii) Include in the notice the items described in paragraph (c)(5) of this section.

§483.15(c)(4) Timing of the notice.
(i) Except as specified in paragraphs (c)(4)(ii) and (c)(8) of this section, the notice of transfer or discharge required under this section must be made by the facility at least 30 days before the resident is transferred or discharged.
(ii) Notice must be made as soon as practicable before transfer or discharge when-
(A) The safety of individuals in the facility would be endangered under paragraph (c)(1)(i)(C) of this section;
(B) The health of individuals in the facility would be endangered, under paragraph (c)(1)(i)(D) of this section;
(C) The resident's health improves sufficiently to allow a more immediate transfer or discharge, under paragraph (c)(1)(i)(B) of this section;
(D) An immediate transfer or discharge is required by the resident's urgent medical needs, under paragraph (c)(1)(i)(A) of this section; or
(E) A resident has not resided in the facility for 30 days.

§483.15(c)(5) Contents of the notice. The written notice specified in paragraph (c)(3) of this section must include the following:

(i) The reason for transfer or discharge;
(ii) The effective date of transfer or discharge;
(iii) The location to which the resident is transferred or discharged;
(iv) A statement of the resident's appeal rights, including the name, address (mailing and email), and telephone number of the entity which receives such requests; and information on how to obtain an appeal form and assistance in completing the form and submitting the appeal hearing request;
(v) The name, address (mailing and email) and telephone number of the Office of the State Long-Term Care Ombudsman;
(vi) For nursing facility residents with intellectual and developmental disabilities or related disabilities, the mailing and email address and telephone number of the agency responsible for the protection and advocacy of individuals with developmental disabilities established under Part C of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (Pub. L. 106-402, codified at 42 U.S.C. 15001 et seq.); and
(vii) For nursing facility residents with a mental disorder or related disabilities, the mailing and email address and telephone number of the agency responsible for the protection and advocacy of individuals with a mental disorder established under the Protection and Advocacy for Mentally Ill Individuals Act.

§483.15(c)(6) Changes to the notice.
If the information in the notice changes prior to effecting the transfer or discharge, the facility must update the recipients of the notice as soon as practicable once the updated information becomes available.

§483.15(c)(8) Notice in advance of facility closure
In the case of facility closure, the individual who is the administrator of the facility must provide written notification prior to the impending closure to the State Survey Agency, the Office of the State Long-Term Care Ombudsman, residents of the facility, and the resident representatives, as well as the plan for the transfer and adequate relocation of the residents, as required at § 483.70(l).

§483.15(d) Notice of bed-hold policy and return-

§483.15(d)(1) Notice before transfer. Before a nursing facility transfers a resident to a hospital or the resident goes on therapeutic leave, the nursing facility must provide written information to the resident or resident representative that specifies-
(i) The duration of the state bed-hold policy, if any, during which the resident is permitted to return and resume residence in the nursing facility;
(ii) The reserve bed payment policy in the state plan, under § 447.40 of this chapter, if any;
(iii) The nursing facility's policies regarding bed-hold periods, which must be consistent with paragraph (e)(1 ) of this section, permitting a resident to return; and
(iv) The information specified in paragraph (e)(1) of this section.

§483.15(d)(2) Bed-hold notice upon transfer. At the time of transfer of a resident for hospitalization or therapeutic leave, a nursing facility must provide to the resident and the resident representative written notice which specifies the duration of the bed-hold policy described in paragraph (d)(1) of this section.

§483.21(c)(2) Discharge Summary
When the facility anticipates discharge, a resident must have a discharge summary that includes, but is not limited to, the following:
(i) A recapitulation of the resident's stay that includes, but is not limited to, diagnoses, course of illness/treatment or therapy, and pertinent lab, radiology, and consultation results.
(ii) A final summary of the resident's status to include items in paragraph (b)(1) of §483.20, at the time of the discharge that is available for release to authorized persons and agencies, with the consent of the resident or resident's representative.
(iii) Reconciliation of all pre-discharge medications with the resident's post-discharge medications (both prescribed and over-the-counter).
Observations:

Based on review of facility policy, clinical records, and staff interview, it was determined that the facility failed to make certain that the necessary resident information was communicated to the receiving health care provider upon transfer to the hospital for two of five residents reviewed (Residents R67 and R71).

Findings include:

Review of facility policy entitled "Transfer Form Instructions" dated 2/24/26, indicated "Should it become necessary to transfer a resident ... a transfer form will be executed and forwarded ..., The transfer form will be completed ... and will include:

Current medical findings
Diagnosis
Summary of the course of treatment followed
Pertinent administrative and social information
Other as necessary and appropriate

Review of Resident R67's clinical record revealed an admission date of 7/8/25, with diagnoses that included heart failure, anxiety disorder (a condition that causes a person to be nervous, uneasy, or worried about something or someone), and hyperlipidemia (high cholesterol).

Review of Resident R67's progress notes revealed notes dated 11/18/25, and 12/17/25, indicating transfers to the hospital. The clinical record lacked evidence that his/her necessary clinical information was communicated to the receiving health care provider.

Review of Resident R71's clinical record revealed an admission date of 12/10/25, with diagnoses that included chronic obstructive pulmonary disease (when your lungs do not have adequate air flow), multiple sclerosis (a disease where the body's immune system attacks the nerves which can cause vision problems, muscle weakness, numbness, feeling tired, difficulty thinking and bowel and bladder dysfunction), and gastro esophageal reflux disease (a condition when stomach acid repeatedly flows back up into your throat).

Review of Resident R71's progress notes revealed notes dated 1/7/26, 1/11/26, 1/16/26, 1/27/26, 2/2/26, and 2/6/26, indicating transfers to the hospital. The clinical record lacked evidence that his/her necessary clinical information was communicated to the receiving health care provider.

During an interview on 3/6/26, at 2:37 p.m. the Director of Nursing confirmed that Resident R67 and Resident R71's clinical records lacked evidence that the necessary clinical information was provided to the receiving healthcare provider upon transfer and that when the transfers occurred clinical information should have been provided to the receiving healthcare provider.

28 Pa. Code 201.18(e)(1) Management

28 Pa. Code 201.29(c.3) (2) Resident rights




 Plan of Correction - To be completed: 04/30/2026

1. The facility can't correct the past clinical records lacking evidence of necessary clinical information being provided to the receiving healthcare provider for residents R67 and R71.

2. The residents that were out at the hospital were reviewed to ensure the necessary clinical information was communicated and documented in the residents' medical record.

3. The director of nursing/designee will re-educate all licensed nurses on the transfer form, including when transferring a resident, they will include the current medical findings, diagnosis, summary of the treatment, pertinent administrative and social information and any other information as necessary and appropriate. Documentation will be recorded in the resident's medical record.

4. The director of nursing/designee will audit the residents that transfer to another health care provider. The audit will include that the documentation is complete for all transfers.

5. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.25(g)(4)(5) REQUIREMENT Tube Feeding Mgmt/Restore Eating Skills:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§483.25(g)(4)-(5) Enteral Nutrition
(Includes naso-gastric and gastrostomy tubes, both percutaneous endoscopic gastrostomy and percutaneous endoscopic jejunostomy, and enteral fluids). Based on a resident's comprehensive assessment, the facility must ensure that a resident-

§483.25(g)(4) A resident who has been able to eat enough alone or with assistance is not fed by enteral methods unless the resident's clinical condition demonstrates that enteral feeding was clinically indicated and consented to by the resident; and

§483.25(g)(5) A resident who is fed by enteral means receives the appropriate treatment and services to restore, if possible, oral eating skills and to prevent complications of enteral feeding including but not limited to aspiration pneumonia, diarrhea, vomiting, dehydration, metabolic abnormalities, and nasal-pharyngeal ulcers.
Observations:

Based on review of facility policy and clinical records, observations and staff interview, it was determined that the facility failed to provide appropriate treatment to prevent potential complications related to a gastrostomy tube (g-tube - a tube inserted through a small incision in the abdomen into the stomach, used for the administration of liquid nutrition and medications) for one of three residents reviewed (Resident R64).

Findings include:

Review of facility policy entitled "Enteral Tube Feeding Care" dated 2/24/26, indicated "Nursing staff will follow physician orders and acceptable clinical standards to ... reduce the risk of infection. Enteral feeding ... tubing must be changed every 24 hours." And "Label feeding bags with the date and time they are hung."

Review of feeding label and manufacturer's guidelines revealed "Hang product up to 48 hours after initial connection when clean technique and only one feeding set are used. Otherwise, hang no longer than 24 hours."

Review of Resident R64's clinical record revealed an admission date of 12/21/26, with diagnoses that included anorexia (a serious eating disorder that causes a fear of weight gain, an how one's body looks leading to a significant weight loss), eating disorder (is a serious mental health condition that causes unhealthy eating behaviors because of how one sees their body and weight), and anxiety (a condition that causes a person to be nervous, uneasy, or worried about something or someone).

Review of Resident R64's physician's orders dated 1/23/26, revealed orders for Jevity 1.5 (feeding) at 75 ml (milliliters) per hour and another order to change piston syringe (a needleless syringe that is used to flush water through a g-tube) every day on the midnight shift for tube feed water flushes dated 2/11/26.

Observations on 3/3/26, at 11:20 a.m. and again at 1:00 p.m. revealed Resident R64's feeding hanging on an IV pole connected to Resident R64's g-tube, the feeding and tubing lacked dates indicating when the tubing and feeding were initiated. Further observations revealed a piston syringe hanging on the IV pole that was dated 2/22/26.

During an interview on 3/3/26, at 1:20 p.m. the Director of Nursing (DON) confirmed that the feeding and the tubing lacked dates indicating when they were initiated and that the piston syringe had a date of 2/22/26. The DON also confirmed that the date should be written on the feeding and tubing when they are initiated and that the piston syringe should have been changed per physician's order.

28 Pa. Code 211.12(d)(1)(5) Nursing services



 Plan of Correction - To be completed: 04/30/2026

1. The facility can't correct the past undated and outdated feeding and tubing for resident R64.The undated feeding and tubing were discarded. The outdated piston syringe was discarded. New supplies were given to the resident per physician's order.

2. All residents with tube feeding were reviewed to ensure accurate dates were on residents feeding, tubing and piston syringe.

3. The director of nursing/designee will re-educate all licensed nurses on dating the feeding, tubing and the piston syringe. The education will include following the physician's order for changing the feeding, tubing and piston syringe.

4. The director of nursing/designee will audit residents on tube feedings five times per week for two weeks then monthly for 3 months to ensure the feeding, tubing and piston syringe have the accurate dates on them.

5. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.25(i) REQUIREMENT Respiratory/Tracheostomy Care and Suctioning:This is a less serious (but not lowest level) deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency is one that results in minimal discomfort to the resident or has the potential (not yet realized) to negatively affect the resident's ability to achieve his/her highest functional status.
§ 483.25(i) Respiratory care, including tracheostomy care and tracheal suctioning.
The facility must ensure that a resident who needs respiratory care, including tracheostomy care and tracheal suctioning, is provided such care, consistent with professional standards of practice, the comprehensive person-centered care plan, the residents' goals and preferences, and 483.65 of this subpart.
Observations:


Based on review of facility policy and clinical records, observation, and staff interview, it was determined that the facility failed to maintain proper care of respiratory equipment and failed to provide oxygen according to physician's orders for two of three residents reviewed for respiratory care (Residents R18 and R23).

Findings include:

Review of facility policy entitled "Oxygen Tubing, Nasal Cannula and Oxygen Mask" dated 2/24/26, indicated "Nursing staff will verify the ordered oxygen flow rate ...," Oxygen tubing, nasal cannulas ... must be replaced at least once every seven days., and New oxygen tubing, cannulas, and mask must be stored in a clean, dry area, open supplies must be protected from contamination."

Review of facility policy entitled "Oxygen Concentrator-Preventative Maintenance" dated 2/24/26, indicated "Air filter ... will need to be cleaned on a weekly basis."

Review of facility policy entitled "Oxygen Administration" dated 2/24/26, indicated "Change pre-filled humidification system at least weekly."

Review of Resident R18's clinical record revealed an admission date of 10/11/25, with diagnoses that include respiratory failure (a condition where your lungs don't exchange air properly), chronic obstructive pulmonary disease (COPD-when your lungs do not have adequate air flow), and anxiety (a condition that causes a person to be nervous, uneasy, or worried about something or someone).

Review of Resident R18's physician's orders revealed an order for supplemental oxygen via nasal cannula (a thin tube with two prongs that fit into the resident's nostrils to deliver oxygen) at two liters/minute every shift dated 10/11/25.

Review of Resident R18's care plans revealed a care plan for COPD with intervention of oxygen therapy as ordered by the physician. Another care plan for respiratory distress with intervention of oxygen continuous per order two liters via nasal cannula.

Observations on 3/3/26 at 12:55 p.m. and again at 1:05 p.m., revealed Resident R18 lying in his/her bed with supplemental oxygen in place via nasal cannula and the oxygen concentrator (machine used to deliver concentrated oxygen to patients) flow rate set at one and a half liters/minute. The nasal cannula lacked a date and the humidification water bottle was empty.


Review of Resident R23's clinical record revealed an admission date of 10/25/24, with diagnoses that included chronic obstructive pulmonary disease (when your lungs do not have adequate air flow), respiratory failure (a condition where your lungs don't exchange air properly), and diabetes (a health condition that is caused by the body's inability to produce enough insulin).

Review of Resident R23's physician's orders revealed an order for oxygen to keep SpO2 (oxygen saturations) at or above 90 percent dated 4/28/25.

Review of Resident R23's care plans revealed a care plan for pneumonia with an intervention that staff will ensure oxygen equipment care/tubing is changed per physician's orders.

Observations on 3/3/26, at 12:54 p.m. and again at 1:05 p.m., revealed an oxygen concentrator sitting next to Resident R23's bed. A filter on the back of his/her oxygen concentrator had a large amount of fluffy white substance covering the filter.

During an interview on 3/3/26, at 1:20 p.m. the Director of Nursing (DON) confirmed that Resident R18's humidification bottle was empty, the nasal cannula lacked a date, and his/her oxygen flow rate was set at one and a half liters per minute and was not in accordance with physician's orders. The DON also confirmed that Resident R23's oxygen concentrator filter was covered with a large amount of fluffy white substance and should be clean.

28 Pa. Code 211.12(d)(1)(5) Nursing services

28 Pa. Code 211.10(c) Resident care policies




 Plan of Correction - To be completed: 04/30/2026

1. The facility can't correct the past error in the flow rate of oxygen delivered by oxygen concentrator for resident R18 and that the nasal cannula lacked a date and the humidifier bottle was empty. Also, that resident R23's filter on the oxygen concentrator needed to be cleaned. The flow rate of oxygen was corrected for resident R18 and a new humidifier bottle was put on the oxygen concentrator. The filter was cleaned on the oxygen concentrator for resident R23.

2. All residents with oxygen were reviewed to ensure the flow rates were set as ordered, the oxygen tubing was dated accurately, the humidification bottle has water, and the oxygen concentrator filters were cleaned.

3. The director of nursing/designee will re-educate all licensed nurses on following the physician's orders for the oxygen flow rate, dating the oxygen tubing, ensuring the humidification water bottle is not empty and cleaning the oxygen concentrator filters per the physician's orders.

4. The director of nursing/designee will audit the oxygen flow rates, oxygen tubing is dated, humidification water bottle, and oxygen concentrator filter is cleaned per physician's orders. The audits will be completed on five residents weekly for 3 months.

5. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.

483.70(n)(1)-(4) REQUIREMENT Hospice Services:Least serious deficiency and is isolated to the fewest number of residents, staff, or occurrences. This deficiency has the potential for causing no more than a minor negative impact on the resident.
§483.70(n) Hospice services.
§483.70(n)(1) A long-term care (LTC) facility may do either of the following:
(i) Arrange for the provision of hospice services through an agreement with one or more Medicare-certified hospices.
(ii) Not arrange for the provision of hospice services at the facility through an agreement with a Medicare-certified hospice and assist the resident in transferring to a facility that will arrange for the provision of hospice services when a resident requests a transfer.

§483.70(n)(2) If hospice care is furnished in an LTC facility through an agreement as specified in paragraph (o)(1)(i) of this section with a hospice, the LTC facility must meet the following requirements:
(i) Ensure that the hospice services meet professional standards and principles that apply to individuals providing services in the facility, and to the timeliness of the services.
(ii) Have a written agreement with the hospice that is signed by an authorized representative of the hospice and an authorized representative of the LTC facility before hospice care is furnished to any resident. The written agreement must set out at least the following:
(A) The services the hospice will provide.
(B) The hospice's responsibilities for determining the appropriate hospice plan of care as specified in §418.112 (d) of this chapter.
(C) The services the LTC facility will continue to provide based on each resident's plan of care.
(D) A communication process, including how the communication will be documented between the LTC facility and the hospice provider, to ensure that the needs of the resident are addressed and met 24 hours per day.
(E) A provision that the LTC facility immediately notifies the hospice about the following:
(1) A significant change in the resident's physical, mental, social, or emotional status.
(2) Clinical complications that suggest a need to alter the plan of care.
(3) A need to transfer the resident from the facility for any condition.
(4) The resident's death.
(F) A provision stating that the hospice assumes responsibility for determining the appropriate course of hospice care, including the determination to change the level of services provided.
(G) An agreement that it is the LTC facility's responsibility to furnish 24-hour room and board care, meet the resident's personal care and nursing needs in coordination with the hospice representative, and ensure that the level of care provided is appropriately based on the individual resident's needs.
(H) A delineation of the hospice's responsibilities, including but not limited to, providing medical direction and management of the patient; nursing; counseling (including spiritual, dietary, and bereavement); social work; providing medical supplies, durable medical equipment, and drugs necessary for the palliation of pain and symptoms associated with the terminal illness and related conditions; and all other hospice services that are necessary for the care of the resident's terminal illness and related conditions.
(I) A provision that when the LTC facility personnel are responsible for the administration of prescribed therapies, including those therapies determined appropriate by the hospice and delineated in the hospice plan of care, the LTC facility personnel may administer the therapies where permitted by State law and as specified by the LTC facility.
(J) A provision stating that the LTC facility must report all alleged violations involving mistreatment, neglect, or verbal, mental, sexual, and physical abuse, including injuries of unknown source, and misappropriation of patient property by hospice personnel, to the hospice administrator immediately when the LTC facility becomes aware of the alleged violation.
(K) A delineation of the responsibilities of the hospice and the LTC facility to provide bereavement services to LTC facility staff.

§483.70(n)(3) Each LTC facility arranging for the provision of hospice care under a written agreement must designate a member of the facility's interdisciplinary team who is responsible for working with hospice representatives to coordinate care to the resident provided by the LTC facility staff and hospice staff. The interdisciplinary team member must have a clinical background, function within their State scope of practice act, and have the ability to assess the resident or have access to someone that has the skills and capabilities to assess the resident.
The designated interdisciplinary team member is responsible for the following:
(i) Collaborating with hospice representatives and coordinating LTC facility staff participation in the hospice care planning process for those residents receiving these services.
(ii) Communicating with hospice representatives and other healthcare providers participating in the provision of care for the terminal illness, related conditions, and other conditions, to ensure quality of care for the patient and family.
(iii) Ensuring that the LTC facility communicates with the hospice medical director, the patient's attending physician, and other practitioners participating in the provision of care to the patient as needed to coordinate the hospice care with the medical care provided by other physicians.
(iv) Obtaining the following information from the hospice:
(A) The most recent hospice plan of care specific to each patient.
(B) Hospice election form.
(C) Physician certification and recertification of the terminal illness specific to each patient.
(D) Names and contact information for hospice personnel involved in hospice care of each patient.
(E) Instructions on how to access the hospice's 24-hour on-call system.
(F) Hospice medication information specific to each patient.
(G) Hospice physician and attending physician (if any) orders specific to each patient.
(v) Ensuring that the LTC facility staff provides orientation in the policies and procedures of the facility, including patient rights, appropriate forms, and record keeping requirements, to hospice staff furnishing care to LTC residents.

§483.70(n)(4) Each LTC facility providing hospice care under a written agreement must ensure that each resident's written plan of care includes both the most recent hospice plan of care and a description of the services furnished by the LTC facility to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being, as required at §483.24.
Observations:

Based on review of clinical record and facility policy, and staff interviews, it was determined that the facility failed to document a physician's order for hospice services for one of one residents reviewed for hospice services (Resident R13).


Findings include:

Review of the current facility policy, entitled "Hospice Care" revealed "Hospice Care will be offered to residents, as ordered by the attending physician, to provide additional supportive care for residents with end-stage terminal illnesses. Nursing staff will ensure there is a current physician's order, physician progress note regarding hospice care, Hospice documentation is current and available on the medical record."

Review of Resident R13's clinical record with an initial admission date of 4/26/23, revealed clinical diagnoses that included Alzheimer's Dementia (A progressive, degenerative brain disease, characterized by memory loss, cognitive decline, and behavioral changes), age related debility, and atrioventricular block first degree (a mild, usually asymptomatic heart rhythm disorder where electrical signals are delayed).

Review of Resident R13's progress notes revealed that he/she was receiving hospice care.

Review of Resident R13's physician's orders failed to reveal an order for hospice services.

During an interview with the Nursing Home Administrator (NHA) and Director of Nursing (DON) on 3/5/26, at approximately 3:30 p.m. the DON confirmed that Resident R13 was on hospice care and did not have a physician's order for hospice and that an order should be entered in the clinical record.


28 Pa. Code 201.14(a) Responsibility of licensee

28 Pa. Code 211.12(d)(3)(5) Nursing services

28 Pa. Code 201.18(b)(1)(3) Management



 Plan of Correction - To be completed: 04/30/2026

I hereby acknowledge the CMS 2567-A, issued to KADIMA REHABILITATION & NURSING AT NEW WILMINGTON for the survey ending 03/06/2026, AND attest that all deficiencies listed on the form will be corrected in a timely manner.



§ 211.12(f.1)(3) LICENSURE Nursing services. :State only Deficiency.
(3) Effective July 1, 2024, a minimum of 1 nurse aide per 10 residents during the day, 1 nurse aide per 11 residents during the evening, and 1 nurse aide per 15 residents overnight.

Observations:

Based on review of facility nursing staffing information and staff interview, it was determined that the facility failed to meet the one NA per 10 residents for the day shift, for one of 21 days reviewed (12/27/25).

Findings include:

Review of nursing staffing documents for the time periods of 12/21/25, through 12/27/25, 1/14/26, through 1/20/26, and 2/26/26, through 3/4/26, revealed the following NA staffing shortage for the day shift:

12/27/25, facility census of 105 residents, 9.88 NA scheduled and 10.50 were required.

During an interview on 3/6/26, at 9:36 a.m. the Nursing Home Administrator confirmed that the facility failed to meet the minimum NA ratio requirements on the above shift and date.





 Plan of Correction - To be completed: 04/30/2026

1. Staffing Nurse Aide ratios can't be corrected for the past date and shift the facility had shortages.

2. The scheduler will complete the nursing schedule based on the Nurse Aide ratios effective July 1, 2024.

3. The Director of Nursing/designee will re-educate the scheduler and Registered Nurse Supervisor's on the facility staffing ratios. If a Nurse Aide reports off, calls will be made to attempt to fill the schedule. If a nurse is scheduled in an aide position, the assignment sheet will specify the hours the nurse worked as an aide.

4. The Director of Nursing/designee will audit the nursing assignment sheets daily for four weeks and weekly for three months to ensure staffing ratios are being met. Results of audits will be presented to the Quality Assurance Performance Improvement Committee Meeting for tracking and trending.


Back to County Map


  
Home : Press Releases : Administration
Health Planning and Assessment : Office of the Secretary
Health Promotion and Disease Prevention : Quality Assurance



Copyright © 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement

Visit the PA Power Port